About Coronin-1A
Coronin-1A (CORO1A) is a protein
from Homo sapiens identified by UniProt accession
P31146, 461 residues long.
MolForge cross-references it against 0 known binders and
344 disease associations.
Target properties
| Protein name | Coronin-1A |
| UniProt accession | P31146 |
| Gene | CORO1A |
| Organism | Homo sapiens |
| Length | 461 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (344)
Diseases linked to this target (Open Targets).
- severe combined immunodeficiency due to CORO1A deficiency · score 0.75
- neurodegenerative disease · score 0.49
- Combined immunodeficiency · score 0.46
- combined immunodeficiency · score 0.46
- Omenn syndrome · score 0.46
- tuberculosis · score 0.37
- severe combined immunodeficiency · score 0.27
- sinoatrial node disorder · score 0.26
- genetic disorder · score 0.19
- tonsillectomy risk measurement · score 0.18
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P31146-F1 | alphafold | PREDICTED | 93.06 | — |
Amino-acid sequence (461 residues)
MSRQVVRSSK FRHVFGQPAK ADQCYEDVRV SQTTWDSGFC AVNPKFVALI CEASGGGAFL VLPLGKTGRV DKNAPTVCGH TAPVLDIAWC PHNDNVIASG SEDCTVMVWE IPDGGLMLPL REPVVTLEGH TKRVGIVAWH TTAQNVLLSA GCDNVIMVWD VGTGAAMLTL GPEVHPDTIY SVDWSRDGGL ICTSCRDKRV RIIEPRKGTV VAEKDRPHEG TRPVRAVFVS EGKILTTGFS RMSERQVALW DTKHLEEPLS LQELDTSSGV LLPFFDPDTN IVYLCGKGDS SIRYFEITSE APFLHYLSMF SSKESQRGMG YMPKRGLEVN KCEIARFYKL HERRCEPIAM TVPRKSDLFQ EDLYPPTAGP DPALTAEEWL GGRDAGPLLI SLKDGYVPPK SRELRVNRGL DTGRRRAAPE ASGTPSSDAV SRLEEEMRKL QATVQELQKR LDRLEETVQA K
Explore Coronin-1A with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets